Introduction
Genetic alterations that deregulate cell fate pathways play an early, critical role in the genesis of specific forms of carcinoma (Vogelstein and Kinzler, 2004) . Mutations that lead to constitutive Sonic Hedgehog (Shh) signaling, such as inactivation of the Ptch1 tumor suppressor, are a consistent step in the development of cutaneous basal cell carcinoma (BCC), the most common malignancy in Caucasians, and may play a role in other tumor types (Goodrich et al., 1997; Callahan and Oro, 2001; Ruiz i Altaba et al., 2002; Berman et al., 2003; McMahon et al., 2003; Pasca di Magliano and Hebrok, 2003; Watkins et al., 2003; Karhadkar et al., 2004) . Although Shh pathway defects are rate-limiting in human BCC, current mouse models exhibit a significant lag between Shh pathway activation and the outgrowth of skin tumors, indicating that defects in other pathways play an important role (Aszterbaum et al., 1999; Grachtchouk et al., 2000; Nilsson et al., 2000; Oro and Higgins, 2003; Hutchin et al., 2005) . Conditional inactivation of the cell fate determinant Notch1 in the skin leads to BCC-like lesions, and p53 mutation is frequent in human BCC (Ling et al., 2001; Nicolas et al., 2003 ). An accurate model of BCC will incorporate these known alterations and will require identification of other genetic or epigenetic changes, the temporal order of alterations, the cell types in which they occur, and the effects of specific mutations on stem cell renewal, cell proliferation, differentiation, and the apoptotic response.
Unlike many other tumor types, BCCs are not associated with an identifiable precursor lesion, and the cell type of origin remains unclear (Miller, 1995) . BCC may originate in stem cell populations found in the follicle bulge and the basal layer of the interfollicular epidermis Tumbar et al., 2004 ). An origin of BCC within the interfollicular epidermis is suggested by induction of BCC-like lesions in the embryonic skin of mice transgenic for Shh or Smo, a seven-transmembrane protein that transduces the Shh signal and exhibits gain-of-function mutations in BCC (Oro et al., 1997; Xie et al., 1998) . However, a conditional Gli2 model showed early tumors associated with the follicle bulge (Hutchin et al., 2005) .
An extensive literature points to the Gli family of zinc-finger transcription factors as mediators of Shh signaling in development and in tumors (Ruiz i Altaba et al., 2002; McMahon et al., 2003; Pasca di Magliano and Hebrok, 2003) . Indeed, either Gli1 or Gli2 can induce BCC in transgenic mice (Grachtchouk et al., 2000; Nilsson et al., 2000; Oro and Higgins, 2003) . Gli proteins are thought to regulate multiple cellular processes relevant to transformation, including cell cycle progression, apoptosis, and others Duman-Scheel et al., 2002; Louro et al., 2002; Yoon et al., 2002; Bigelow et al., 2004; Callahan et al., 2004) . However, few downstream effectors have been extensively characterized.
As one of its multiple roles in development, Shh signals to the epithelial ventromedial somite wall to induce the connective tissue mesenchyme of the slcerotome, an example of epithelial-mesenchymal transition (EMT) (Fan and Tessier-Lavigne, 1994; Hay, 1995; Thiery, 2003) . We previously utilized a conditional Gli1-estrogen receptor fusion protein (Gli1-ER) to show that Gli1 can rapidly and directly induce expression of Snail, a regulator of EMTs in embryonic development and in tumor progression (Louro et al., 2002) . Snail and Gli1 transcripts were prominent in human BCCs, and in adjacent normal anagen hair follicles. Furthermore, when expressed in AT2 prostate cancer cells with low metastatic potential, Gli1-induced prominent expression of Snail and a more metastatic phenotype (Karhadkar et al., 2004) . Conversely, treatment of Snail-positive, highly metastatic AT6 prostate cancer cells with the Shh pathway inhibitor cyclopamine inhibited both Snail expression and the metastatic phenotype.
In the current study, we used tetracycline (tet)-inducible strategies to correlate Gli1 and Snail expression in vitro and in vivo. In the interfollicular epidermis, Gli1 induced expression of Snail and cell proliferation within 6-12 h of induction. By 4 weeks, superficial lesions with molecular and morphologic similarities to BCC were observed. A functional role for Snail in vivo was suggested by loss of E-cadherin in Gli1-induced skin lesions. Studies performed in an epithelial model in vitro supported our previous observation that Snail is directly regulated by Gli1 (Louro et al., 2002) , and indicated that Snail is a limiting factor in Gli1-induced transformation that recapitulates the cell morphologic changes induced by Gli1.
Results

Rapid induction of Snail by Gli1 in vitro
Previously, we utilized an E1a-immortalized, epithelial line derived from rat kidney, termed RK3E, to identify a gene expression profile for Gli1 (Ruppert et al., 1991; Louro et al., 2002) . Unlike control RK3E cells and RK3E cells transformed by c-Myc, Ras, or Klf4/Gklf, Gli1-transformed cell lines showed prominent expression of Snail. Direct regulation was suggested by rapid induction of Snail transcripts upon exposure of Gli1-ER cells to tamoxifen, even in the presence of the protein translation inhibitor cycloheximide. Although induced by Gli1, the functional significance of Snail to Gli1-induced transformation remained unclear.
To further examine Snail as a potential transcriptional target of Gli1, we isolated clones of RK3E cells in which a human Gli1 allele is induced by tet (Figure 1a ). Immunoblot analysis identified several clones with a low background of Gli1 in uninduced cells and prominent expression after exposure to tet for 6 h (left panel). Expression of transcripts corresponding to Snail and the well-established Gli1 target gene, Ptch1, were examined by semi-quantitative reverse transcription and PCR (RT-PCR, right panel). Analysis of multiple clones revealed consistent regulation of Snail and Ptch1. When RTOG10 cells were similarly analysed over a time course, Snail and Ptch1 were coregulated and induced by 1-3 h, consistent with direct regulation of these by Gli1 (Figure 1b) (Agren et al., 2004) . When expressed in a variety of epithelial cell types, Snail inhibits expression of E-cadherin and induces features of EMT (Batlle et al., 2000; Cano et al., 2000) . We generated puromycin-resistant RK3E cell populations by retroviral transduction of pBABE-puro Snail (termed Snail cells) or pBABE-puro vector (termed Vector cells). Snail cells and Vector cells exhibited similar growth rates at subconfluence, a similar frequency of apoptosis as indicated by condensed nuclei, and were similarly contact inhibited at confluence (data not shown, and see below). In contrast to Vector cells, Snail cells showed reduced expression of E-cadherin (Figure 1c) , and phase-contrast microscopy revealed prominent blebbing of the cytoplasmic membrane ( Figure 1d , middle panel). This phenotype was previously described in other cell types and was attributed to impaired mechanical stability of actin filaments underlying the cell membrane (Cunningham et al., 1997; Flanagan et al., 2001) . Like Snail cells, Gli1 cells have reduced expression of E-cadherin ( Figure 1e ) and exhibit blebbing (clones Gli-A and Gli-C; e.g., Figure 1d , bottom panel).
The typical features of EMT, such as acquisition of a spindled morphology, were not apparent in Snail cells (Figure 1d ). Nor was cell migration altered, as indicated by a wound healing assay in vitro (data not shown) (Cano et al., 2000) . Absence of these features may be attributed to expression of E1a, which strongly promotes the epithelial phenotype (Frisch, 1994) , or to lower levels of Snail protein in these cells compared with previous studies (Batlle et al., 2000; Cano et al., 2000) . Transgene expression in Snail cells was not detected by immunoblot or indirect immunofluorescence using antiSnail antibody (Santa Cruz), or else 12CA5 antibody against the C-terminal hemagglutinin (HA) epitope. Nor was protein expression observed when Snail cells were transformed with Gli1 or Ras, treated with the proteasome inhibitor MG132, or when GSK3b was inactivated with LiCl (Zhou et al., 2004; Yook et al., 2005) . In these experiments, Cos-7 cells transiently expressing the same HA-tagged transgene served as a positive control, and yielded a strong signal on immunoblots (data not shown). Thus, the level of transgene-derived Snail in RK3E cells and transformed derivatives is low, even though its activity is evident as described below.
Characterization of dominant-negative Snail
Mayor and co-wokers generated truncated alleles of Xenopus Snail that functioned as dominant negatives (Aybar et al., 2003) . To examine a role of Snail in mammalian cells, we generated fragments of mouse Snail and tested these for inhibition of the wild-type protein (Figure 2a and b ). Of several alleles tested in HEK293 cells, only SnaDZFD and SnaZFD could specifically antagonize the activity of Snail on the Ecadherin promoter. Titration experiments identified SnaZFD as the more potent of the two, as E-Cadherin transcription was restored using 0.5 mg of plasmid, equal to the input of wild-type Snail (Figure 2b , compare lanes 3 and 6). SnaZFD was likewise more active than SnaDZFD when the input was twice that of wild type (compare lanes 4 and 7), which was sufficient to saturate the effect (compare lanes 4 and 5). Consistent with inhibition of Snail by the truncated proteins, coexpression of the two was not additive or synergistic (Figure 2b, lane 8) . Induction of E-cadherin promoter activity beyond levels obtained without exogenous Snail suggested the presence of an endogenous repressor (Figure 2b, compare lanes 3, 4, 5, 7 , and 8 to lane 1). Indeed, Snail is expressed in HEK293 cells (Figure 2c ). The activity of truncated Snail alleles on the E-cadherin promoter, their lack of activity on the Renilla control (data not shown), and their overall similarity to the Xenopus dominant-negative alleles previously characterized are consistent with their function as dominant negatives.
Induction of endogenous Snail is limiting for Gli1-induced transformation in vitro
To determine if Snail has a role in transformation by Gli1, we expressed SnaZFD under control of the Moloney murine leukemia virus long terminal repeat (MMLV-LTR). Following lipid-mediated co-transfection with Gli1 expression vector, SnaZFD repressed the outgrowth of transformed foci by 69% (mean number of foci/dish: Gli1 þ Vector, 87; Gli1 þ SnaZFD, 27; Figure 2d , column 1, compare rows 1 and 2; and Figure 2e ).
In multiple transformation assays, expression of Snail alone did not induce foci (Figure 2d , column 4, row 3). However, induction of Snail appeared to be a limiting factor in Gli1-induced transformation, as co-transfection of Snail with Gli1 induced focus formation by 5.5-fold (mean number of foci/dish: Gli1 þ Vector, 87; Gli1 þ Snail, 475; Figure 2d , column 1, compare rows 1 and 3; and Figure 2e ).
As a complementary approach, we used sequential retroviral transduction to determine the transforming efficiency of Gli1 or N-Ras retroviral supernatants when applied to pooled populations of puromycin-resistant cells transduced with pBABE-puro (Vector cells) or pBABE-puro-Snail (Snail cells; described above, Figure 1d ). In three independent experiments, each performed in duplicate, Gli1 induced an average of 5.4-fold more foci in Snail cells compared with Vector cells (mean foci/dish, 514 vs 95), whereas the two cell lines showed a similar number of foci in response to N-Ras (92 vs 87 foci/dish; Supplementary Figure 1) . Thus, Snail cooperates with Gli1 but not with N-Ras.
Snail and SnaZFD may modulate Gli1 transformation in a pathway-specific fashion or have a nonspecific effect on cell proliferation. To address this issue, we transfected these constructs into RK3E cells in combination with the intracellular domain of Notch 1 (NICD), previously reported to transform RK3E cells (Ascano et al., 2003) , or an activated allele of ErbB2 that transforms these cells more efficiently than the wildtype allele (unpublished data, MHK). Neither Snail nor SnaZFD altered the transforming efficiency of the controls ( Figure 2d , columns 2 and 3; and Figure 2e ).
Thus, Snail specifically modulates transformation by Gli1.
To further address the possibility that Snail and SnaZFD may alter cell growth in a nonspecific fashion, colony size and number were determined following transfection of MMLV-LTR plasmids into RK3E. Puromycin selection was applied 24 h post-transfection, and colonies were analysed at 7 days ( Figure 2d , column 5). As indicated by colony-forming efficiency, colony size, and cell density within the colonies, neither Snail nor SnaZFD exhibited an apparent growth phenotype in nontransformed RK3E. The colony assay supports the similar growth properties noted above for RK3E-Snail and RK3E-Vector cells (Figure 1c and d) . In
Role of Snail in transformation by Gli1
X Li et al contrast to these results, transfection of Gli-C or Gli-A with SnaZFD produced fewer colonies compared with Vector (data not shown). Overall, the results shown in Figure 2d and e indicate that Snail promotes transformation in an oncogene-specific fashion, and is largely dispensable for transformation by NICD and ErbB2.
If the activity of SnaZFD in Gli1 transformation assays is due to interference with Snail, it might restore E-cadherin in Gli1 cells. We therefore examined Ecadherin by indirect immunofluorescence following transient transfection of E-cadherin-low Gli-C cells with the pcDNA3.1-SnaZFD vector (Figure 2f ). For these studies, an electroporation protocol was optimized to enable transfection of >95% of cells, as indicated by a green fluorescent protein (GFP) control (not shown). Gli-C cells transfected with a vector control exhibited diffuse cytoplasmic staining and discontinuous, punctate membrane staining, but rarely exhibited continuous staining along the circumference of the cell (Figure 2f , Vector). In contrast, transfection with SnaZFD yielded cells with continuous staining along the cell periphery in nearly all fields examined (Figure 2f , SnaZFD). Immunoblot analysis revealed Btwo-fold induction of Ecadherin by SnaZFD (not shown), consistent with restoration of E-cadherin expression in a subset of cells.
Snail short hairpin RNAs restore E-cadherin in Gli1 cells and suppress RK3E transformation by Gli1
While inhibition of Gli1 transformation by SnaZFD is consistent with gain-of-function data indicating a role for Snail in this process, the dominant negative allele contains a conserved DNA-binding domain that might compete with other E-box binding proteins (Bolos et al., 2003) . To further address a specific role for Snail, we generated six Snail short hairpin RNA (shRNA) expression contructs (pSna sh1À6 ) and a control (pSi Ctl ) by insertion of annealed oligonucleotides downstream of a U6 promoter (Table 1). As described above for SnaZFD, each was cotransfected with Gli1 into RK3E cells (Figure 3a and b ) was weakly inhibitory, and one (pSna sh1 ) had no effect.
To correlate shRNA modulation of Gli1 transformation with repression of Snail, constructs were analysed for their ability to reduce Snail mRNA (Figure 3c ) or to restore E-cadherin expression (Figure 3d) and pSna sh5 , in correlation with their relative Gli1-inhibitory activities (Figure 3c , Table 1 ). Immunoblot analysis showed that expression of E-cadherin, unlike bactin, was increased in Gli1 cells by two active shRNAs but not by the inactive pSna sh1 (Figure 3d ). In summary, Snail shRNAs that inhibited transformation by Gli1 also inhibited Snail and induced expression of Ecadherin. Thus, both gain-and loss-of-function studies The strand shown corresponds to the final RNA Polymerase III transcript, with the +1 base in bold. Restriction sites, hairpin loop sequences, and terminator sequences are upper case Role of Snail in transformation by Gli1 X Li et al indicate that Snail induction is limiting for Gli1-induced transformation.
Conditional expression of Gli1 in the skin
Expression of Gli1 or Gli2 in mouse skin induces outgrowth of BCC-like tumors (Grachtchouk et al., 2000; Nilsson et al., 2000; Oro and Higgins, 2003; Hutchin et al., 2005) . To examine early events following induction of Gli1, we employed the same tet-on strategy that we used for analysis of Klf4 (Foster et al., 2005) (Figure 4a ). In this approach, an X chromosome-linked reverse tet-responsive transactivator (rtTA X ) is expressed under control of a Keratin 14 (K14) promoter, and administration of doxycycline (dox) results in rapid activation of tet response element (TRE)-linked transgenes.
Founders were identified using a PCR assay in which the endogenous mouse alleles served as an internal reference (Figure 4b) . Each of five founders was crossed to K14-rtTA animals. The progeny were induced with dox and monitored for a skin phenotype.
Gli1 rapidly induces hyperplastic lesions in the skin
Three of the five TRE-Gli1 lines showed dorsal hair loss and outgrowth of discrete skin lesions after 4 weeks of induction (Figure 4c) . Grossly, lesions affected the back, neck, and ears, and appeared as clusters of flattened or slightly raised plaques, with each plaque measuring one to several mm in diameter. Lesions were yellowish in color, and microscopic analysis showed nests of basaloid cells budding from the epidermis, with extension into the dermis (Figure 4c ). There was no difference in latency when 4-week inductions were initiated in mid-gestation, in 14-day-old pups, at 6 weeks, or in older adults. Thus no specific role of the hair follicle cycle was apparent (not shown). This result is in contrast to the restriction of Gli1 activity to anagen phase skin in mice with expression of Gli1 under control of a constitutive K14 promoter (Oro and Higgins, 2003) . This difference between the two models may be attributed to different expression strategies and/or distinct genetic backgrounds. In the studies shown below, we utilized TREGli1 line #10.
Immunostaining identified similarities between Gli1-induced skin lesions, hair follicles and BCCs. Established lesions showed uniform expression of K17, a marker of follicles and BCCs that was recently implicated as a direct transcriptional target of Gli family members (Callahan et al., 2004) (Figure 5a and b). K16 marks hyperproliferative skin and is typically positive in squamous cell carcinoma (SCC), but negative in BCC. This cytokeratin was low in normal epithelial cells (Figure 5c ), and likewise low in basaloid cells composing most of the lesion, but was positive in maturing keratinocytes overlying the hyperproliferative cells (Figure 5d ). K1, which is normally induced upon commitment to terminal differentiation (i.e., in the parabasal cells of normal dorsal skin, Figure 5e ), stained only the most superficial layer of cells within lesions, indicating a delay of differentiation, and did not stain the basaloid cells budding into dermis (Figure 5f ). K14 marked the basal layer in normal skin (Figure 5g ) and was uniformly positive within lesions (Figure 5h) .
We utilized anti-HA antibody and indirect immunofluorescence to localize the Gli1 protein within lesions (Figure 6a ). Gli1 was expressed in the interfollicular hyperproliferative epithelium, and in the outer root sheath of follicular epithelial cells. Consistent with the tight control of expression in this system (Foster et al., 2005) , Gli1 was not detected without induction (Figure 6b ). The strictly conditional nature of Gli1 expression in these animals is consistent with the absence of any skin phenotype in uninduced animals, and with the overall excellent health and fecundity of the transgenic lines. Primary keratinocytes obtained from bitransgenic mice exhibited prominent staining of the cytoplasm and nucleus following treatment with dox (Figure 6c-e) . At subconfluence in calcium-low culture media, these cells failed to exhibit any morphologic, proliferative, or apoptotic response to Gli1 (data not shown). The absence of any apparent phenotype of Gli1 in these cells is consistent with the limited effect of Gli1 when expressed alone in other primary rodent cells (Ruppert et al., 1991) . The failure of Gli1 to affect keratinocyte morphology or growth rate at subconfluence recapitulates results obtained when Shh was expressed in primary human keratinocytes (Fan and Khavari, 1999) . Our studies do not preclude more subtle effects of Gli1, such as alteration of cell cycle occupancy following a differentiation stimulus or induction of increased cell density at confluence, both of which were observed for Shh.
While these rapidly induced, diffuse basaloid lesions exhibit certain molecular and morphologic similarities to BCC, they failed to form the large, focal tumors observed following longer term expression of Gli1 or Gli2 (Grachtchouk et al., 2000; Nilsson et al., 2000; Hutchin et al., 2005) . We therefore sought to modify the phenotype by introducing genetic alterations observed in human tumors. We introduced deficient alleles of p53 and Ptch1, respectively, to obtain K14-rtTA X ;TREGli1;p53 þ /À and K14-rtTA X ;TRE-Gli1;Ptc1 þ /À mice. In p53 þ /À animals, Gli1-induced lesions were significantly enhanced, with a 2.3-fold increase in thickness (mean 194 vs 83.3 mm, Po0.0001; Supplementary Figure 2 ). These enhanced lesions had prominent neovascularization, perhaps due to the increased growth potential of mesenchymal cells in p53 þ /À animals, and/or to proliferative signals emanating from the neoplastic cells. In contrast to p53, the Gli1-induced skin phenotype was not altered in Ptc1 þ /À animals (data not shown).
Gli1 rapidly induces Snail transcripts and cell cycle progression in the interfollicular epidermis
To temporally correlate activation of Gli1 with induction of Snail in vivo, we examined expression of the human Gli1 transgene and endogenous Snail and K17, and monitored BrdU incorporation at intervals following administration of dox to bitransgenic mice ( Figure 7 ). For these studies, littermates were induced at 40 days of age, when the hair follicle cycle is still synchronized and in the telogen phase. Prior to induction there was no detectable expression of Gli1, Snail, or K17 in the interfollicular epidermis, and, of these, only K17 was present in normal follicle cells (Figure 7a , e, i, and m). In the 6-12 h interval following induction with dox, interfollicular cells concomitantly upregulated Gli1 and Snail, and incorporated more BrdU (Figure 7b, f and j) . These increased until 48 h (Figure 7a-l) . Sections from t ¼ 6 h mice stained like t ¼ 0 h (not shown). Telogen follicle cells were slower to respond, showing increased Gli1, Snail, and BrdU signals only at 48 h. Compared to Snail and BrdU incorporation, K17 was slower to respond in the interfollicular cells, and became prominent only at 48 h. Thus, K17 may not be directly regulated by Gli1 in this setting, or its expression in interfollicular cells is restricted (Figure 7m-p) .
To determine if Snail is active during outgrowth of skin lesions, we examined E-cadherin in tissue sections from these same animals and from an animal with Figure 5 Immunostaining of Gli1-induced lesions. Dox was administered to wild type (Wt) or TRE-Gli1 mice for 4 weeks, and the indicated antibodies were applied to sections of dorsal skin. Arrowheads indicate the dermo-epidermal junction (DEJ). Scale bar, 50 mm (Figure 8a ). E-cadherin largely persisted through the first 48 h of induction, although at this timepoint expression was lower in the interfollicular epidermis compared with adjacent follicle cells on the same slide ( Figure 8b ). This differential effect is consistent with the more rapid induction of Gli1, Snail, and BrdU in interfollicular epidermis compared to telogen follicles ( Figure 7 ). More strikingly, E-cadherin was markedly reduced in established lesions, particularly in dysplastic basaloid cells infiltrating the dermis (arrowheads, Figure 8c ). In the interfollicular cells of these animals, E-cadherin staining was lower where lesion thickness was greater (Figure 8c ). These results recapitulate the loss of E-cadherin expression in infiltrating human BCC (Pizarro et al., 1994) , and indicate that Snail may repress E-cadherin in response to Gli1 in vivo.
Discussion
Conditional expression of Gli1 in RK3E cells and in the basal keratinocytes of mouse skin demonstrated a temporal correlation of Shh pathway activity with Snail expression, and identified Snail as an early response to Gli1. Using a Snail dominant-negative allele, multiple Snail shRNAs, and enforced expression of wild-type Snail, we identified Snail as a critical downstream effector of Gli1. Co-transfection of Gli1 with SnaZFD, Vector, and Snail represents a type of allelic series, with progressively increasing Snail activity. At the extremes, coexpression of SnaZFD vs wild-type Snail altered Gli1 transforming activity by 18-fold. Snail appeared specific in its ability to cooperate with Gli1, indicating that the mechanism of transformation by Gli1 is distinct from that of N-Ras, ErbB2, or Notch1. Such specificity is consistent with the induction of Snail by Gli1, but not by other proteins such as Klf4 or c-Myc (Louro et al., 2002; Karhadkar et al., 2004) . Our studies indicate that, in epithelial cells, the Shh signaling pathway extends to Snail to effect transformation in vitro. This signaling is a potential mechanism of E-cadherin repression in human BCC and other tumor types (Pizarro et al., 1994; Louro et al., 2002; Karhadkar et al., 2004) . EMT occurs at gastrulation and during formation of the neural tube, somites, and cardiac valves, and is essential for the establishment of complex three-dimensional tissues from epithelial precursors (Hay, 1995; Nieto, 2002; Thiery, 2003) . Unlike epithelial cells, mesenchymal cells can invade and migrate through the Figure 7 Skin alterations in the period immediately following induction of Gli1. Dox was added to the drinking water of 40-day-old K14-rtTA X ;TRE-Gli1 littermates for the indicated interval, and the telogen-phase skin was analysed. Expression of Gli1 (a-d) and Snail (e-h) were monitored by in situ hybridization using antisense RNA probes. A Snail sense probe served as negative control and exhibited no signal in any section (not shown). BrdU incorporation (i-l) and K17 expression (m-p) were determined by immunostaining. Sections taken at 6 h were similar to the zero timepoint, indicating that Gli1, Snail, and BrdU were coinduced at 6-12 h. Arrowheads point to the DEJ. Insets (e-h) show the epidermis at higher magnification. Scale bars, 50 mm extracellular matrix. EMT is partially or completely recapitulated invasive human carcinomas, such as BCC, and is believed to be a late event in tumor progression, when cells finally exit the epithelial compartment and become invasive and/or metastatic. EMT is regulated by signals that normally control cell fate, including the TGFb, Notch, and Shh pathways (Hay, 1995; Thiery, 2003) . During normal development and tumor progression, EMT is often linked to Snail family members such as Snail or Slug (Snai2) (Nieto, 2002) .
In addition to their role in EMT, Snail family members function as regulators of proliferation or apoptosis (Batlle et al., 2000; Cano et al., 2000; Vega et al., 2004; Bachelder et al., 2005; Jamora et al., 2005; Savagner et al., 2005) . Although expression in some cell types in vitro induces growth arrest, in other settings Snail induces proliferation and/or inhibits cell death. When expressed in the basal keratinocytes of transgenic mice under control of a K14 promoter, Snail activated the RAS-Mitogen-activated protein kinase pathway, repressed expression of components of the hemidesmosomes and the underlying basemement membrane, and induced proliferation (Jamora et al., 2005) . GSK3b represses Snail in keratinocytes (Bachelder et al., 2005) , and Slug is an effector of cell migration during wound healing in the skin (Savagner et al., 2005) . Thus, the normal function of Snail family members extends beyond development to include homeostasis and healing in adult epithelium.
Both Shh and Snail are implicated in folliculogenesis. Shh-deficient mouse embryos initiate hair follicle morphogenesis, but follicles arrest at an early stage due to impaired epithelial proliferation and failure to form a dermal papilla (St Jacques et al., 1998; Chiang et al., 1999; Callahan and Oro, 2001 ). In addition, Shh and Gli1 are expressed in the distal portion of adult anagen follicles, probably to enable rapid downward expansion (Ghali et al., 1999; Oro and Higgins, 2003) . Gli1 signaling through Snail may contribute in several respects to this process, promoting epithelial proliferation and remodeling of the basement membrane and dermis. We previously identified transcripts of Snail, Gli1, and multiple Gli1 target genes in morphologically normal anagen follicles adjacent to human BCCs (Louro et al., 2002) . Similarly, Snail is transiently induced in proliferating epithelial cells of the embryonic hair bud, through the action of TGFb2 (Jamora et al., 2005) .
Our observation that Snail, like Gli1, induces membrane blebbing may help explain the minimal morphological alteration of RK3E cells upon transformation by Gli1 (Ruppert et al., 1991) . In contrast to Gli1 cells, RK3E cells transformed by Ras or Klf4 show prominent membrane extensions and markedly increased spindling and refractility. Membrane blebbing has been ascribed to the inability of cells to produce more typical membrane extensions, possibly because of reduced viscosity of the peripheral actin gel (Cunningham et al., 1997; Flanagan et al., 2001; Straight et al., 2003) . For melanoma cells, a tumor type that consistently expresses Snail (Poser et al., 2001) , this phenotype is attributed to deficiency in the crosslinking protein Filamin A/Actin-binding protein. Our results link Snail expression to membrane blebbing, which may result from reduced expression of E-cadherin and/or from another activity of Snail (Ohkubo and Ozawa, 2004) . Whether this indicates a role of Snail in regulation of Filamin A or other components of the cortical actin gel warrants further study.
Previously it was shown that constitutive Shh or Smo transgenes induced BCC-like lesions in the interfollicular epithelium of embryonic mouse skin (Oro et al., 1997; Xie et al., 1998) . Our results demonstrate that Gli1 can rapidly convert interfollicular keratinocytes to proliferating, Snail-positive cells with morphological and molecular similarities to BCC. The tet-on Gli1 mouse showed clearly that adult, mammalian interfollicular epidermis, a setting relevant to human BCC tumorigenesis, is competent to rapidly respond to Shh pathway activity.
Under regulation of the same K14-rtTA transgene as used in the current study, Klf4 induced SCC-like lesions, with nuclear hyperchromicity and pleomorphism of superficially invading cells (Foster et al., 2005) . The distinct phenotypes induced by Gli1 or Klf4 in the skin are consistent with expression studies and genetic data linking these genes to BCC and SCC tumorigenesis, respectively (Dahmane et al., 1997; Foster et al., 1999 Foster et al., , 2000 Foster et al., , 2005 . Unlike Gli1-induced lesions, Klf4-induced lesions were negative for K17 and diffusely positive for 
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X Li et al K1 and K16. In contrast to the BCC phenotype induced by constitutive Gli1 transgenes (Nilsson et al., 2000; Oro and Higgins, 2003) , the limited growth induced by shortterm expression of Gli1 in our study suggests that other alterations are needed for progression to BCC. Such alterations may involve other Shh pathway members, such as Gli2 or Gli3, or BCC tumor suppressors such as Notch1. In addition, it will be important to examine the role of Snail in Shh-pathway mediated tumor progression in vivo, using gene deletion or conditional expression of Snail antagonists such as SnaZFD or Snail shRNAs.
Materials and methods
Plasmid construction
For tet-on induction in RK3E cells, an HA-tagged allele of human, wild-type Gli1 was released from pBluescript (Louro et al., 2002) using XbaI and HindIII, blunted with T4 polymerase, and cloned into the EcoRV site of pcDNA4/TO (Invitrogen).
For generation of TRE-Gli1 transgenic mice, the HA-Gli1 cDNA was linker-adapted and inserted into the XbaI site of pXP2-TRE-hGFAT (a gift from JE Kudlow). For microinjection, a 5.7 kb fragment was released using SalI and ClaI.
SnaZFD, encoding bases 366-841 of Genbank accession M95604, was amplified from first strand cDNA of mouse NIH3T3 cells. The forward primer (5 0 cgcggatcccgctctgg ccaacatggcctcctccctggag3 0 ) contained a BamHI site (underlined) followed by translation initiator sequences (italics) and a region upstream of the ZFD. The reverse primer (5 0 ccggaattcaagatgccagcgaggat3 0 ) contained an EcoRI site (underlined) and hybridized to the Snail 3 0 UTR. SnaDZFD, encoding the region up to base 488 of M95604, was released from pcDNA3-mmSnail-HA (Batlle et al., 2000) using BamHI and SspI. For use in transient transfection assays, the fragments were inserted into the pcDNA3.1 þ (Invitrogen) and verified by sequencing. For stable expression, inserts were transferred to the MMLV-LTR vector pBABE-puro (Morgenstern and Land, 1990) .
Employing recombinant PCR, alanine 648 (GCC) in the wild-type ErbB2 cDNA (NM_004448) was altered to encode cysteine (TGC) (di Fiore et al., 1987; Kraus et al., 1987) . The XhoI-adapted ErbB2 coding sequence was cloned into the SalI site of pBABE-puro to yield pBpuro-ErbB2
A648C
. The mouse Notch1 cDNA (NICD), a gift of C Jane McGlade (McGill and McGlade, 2003) , was inserted into pBABE-puro.
Duplexes encoding Snail shRNAs (Table 1) were cloned into pSilencert 2.1-U6 neo (Ambion), transfected into XL1-Blue cells (Stratagene), and verified by sequencing. pSi Ctl encodes a hairpin transcript without identity or perfect complementarity to Snail or other cellular transcripts in Genbank (release 147.0), and was constructed by reversal of sequence in pSna Sh4 .
Cell transfection and retroviral transduction
pcDNA4/TO-HA-Gli1 and pcDNA6/TR (Invitrogen) were linearized with ScaI and SapI, respectively, purified from an agarose gel (Qiagen), and transfected at a 1:6 mass ratio into RK3E cells by electroporation (parameters available upon request). Colonies were selected in blasticidin (1.0 mg/ml) and zeocin (Invitrogen, 10.0 mg/ml). At 2 weeks post-transfection, individual clones were transferred to 24-well plates and expanded for further analysis.
Gli1 and H-Ras expression plasmids used for in vitro transformation assays were described previously (Ruppert et al., 1991) . Focus assays were performed in 10 cm dishes, without selection, following Lipofectamine-mediated plasmid transfection (Invitrogen) (Ruppert et al., 1991) . For analysis of Snail, SnaZFD and shRNAs, 2.0 mg of Gli1, NICD, or ErbB2 vector were co-transfected with 8.0 mg of the indicated plasmid. Retroviral transduction of RK3E and selection in puromycin were previously described (Foster et al., 1999; Louro et al., 2002) . Colony assays following plasmid transfection utilized selection in puromycin. Transformation by retroviral transduction used the MMLV-LTR vector pLJD-HA-Gli1 (Louro et al., 2002) , pCTV4-N-Ras (a gift of Robert Kay), and pLJD (a control). Phase contrast microscopic images were captured using an Axiovert 25 inverted microscope equipped with an Axiocam digital camera (Zeiss).
Transient transfection and luciferase reporter assays
At 24 h before transfection, HEK293 cells were plated at 2 Â 10 5 cells per well in six-well plates. Transfection mixtures included 0.5 mg of E-cadherin promoter-luciferase reporter plasmid (Batlle et al., 2000) , 0.1 mg of Renilla luciferase reporter, 0.5 mg of pcDNA3.0-mmSnail-HA (Batlle et al., 2000) and the indicated amount of pcDNA3.1-SnaZFD, pcDNA3.1-SnaDZFD, or pcDNA3.1 (Invitrogen). pcDNA3.1 was used to standardize the total amount of DNA. TransIT s LT1 Reagent (6 ml, Mirus) was used according to the manufacturer's instructions. Extracts were prepared in passive lysis buffer and luciferase activities were determined 48 h posttransfection.
Generation and analysis of transgenic mice C57BL/6 (B6) X SJL (J) F2 fertilized ova were treated by microinjection in the Transgenic Animal/Embryonic Stem Cell Core Facility at the University of Alabama at Birmingham. Transgenic founders were identified by PCR. PCR primers for genotyping were 5 0 cctgttggggatgctggatgg3 0 and 5 0 ggcctcagctccctggagca3 0 . TRE-Gli1 founders were crossed to B6;J F2 animals, and these lines were subsequently crossed to mice transgenic for X chromosome-linked alleles of K14-rtTA. Following fixation and embedding in paraffin, hematoxylinand eosin-staining was performed by the Tissue Procurement Core Facility of the University of Alabama at Birmingham. The described gross or microscopic results were observed in five or more animals, with complete penetrance.
To generate TRE-Gli1 mice with the genotypes indicated for K14-rtTA X and p53, the three crosses used (male X female) were:
;rtTA X þ / þ . Oligonucleotides, cycling parameters, and electrophoretic parameters for genotyping are available upon request. Dox (Sigma) was administered at 2.0 mg/ml in 5% sucrose water in amber bottles and was changed three times per week.
Immunostaining
Keratins were detected in paraffin sections as described (Foster et al., 2005) . K17 polyclonal antibody, a gift from Pierre Coulombe, was used at 1:2000 (McGowan and Coulombe, 1998) . Immunodetection was performed using the brown chromogen diaminobenzidine (BioGenex).
E-cadherin was detected in Gli1 cells at 72 h post-transfection, or in RK3E cells, using primary antibody at 0.5 mg/ml (BD Biosciences, #610181) and a red fluorescent secondary antibody as described (Pandya et al., 2004) . For analysis of transfected cells, 20 random fields were examined at 400-fold magnification, and images corresponding to representative fields were recorded using epifluorescence. HA-Gli1 was similarly detected in primary keratinocytes using 12CA5 (Roche). For detection of HA-Gli1 in vivo, mouse skin cryosections were fixed for 10 min at room temperature in 4% paraformaldehyde in phosphate buffered saline (PBS), rinsed in PBS, and blocked in 20% goat serum in binding buffer (Pandya et al., 2004) . The rat anti-HA antibody 3F10 (Roche) was used at 0.5 mg/ml in 2% goat serum, and bound antibody was detected using a red fluorescent secondary antibody (Molecular Probes, #A11017). Nuclei were stained in DAPI and digital images were captured as described (Pandya et al., 2004) .
mRNA expression studies
For RT-PCR analysis of cultured cells, total RNA was extracted using RNeasy (Qiagen). RT reactions contained 3.0 mg of total RNA per sample, oligo-dT(12-18) at 50 mg/ml, and SuperScriptt II RT (Invitrogen). First-strand product was diluted to 200 ml, and 1-3 ml was used as PCR template. Primers are shown in Supplementary Table 1. PCR reactions were terminated at intervals between 18 and 30 cycles, and products were detected by scanning of ethidium-bromide stained gels using a Typhoon 8600 (GE Biosystems). For selected samples, variation of input cDNA was used to ensure the semi-quantitative nature of the reactions.
mRNA in situ hybridization analysis of paraffin-embedded sections of mouse skin was performed using digoxigenin (dig)-labeled transcripts as described (Bardelli et al., 2003) . Templates for in vitro transcription were isolated from total mRNA of mouse NIH3T3 cells by RT-PCR, and PCR primers incorporated a T7 RNA polymerase binding site. Forward and reverse primers for Gli1 were as described (Louro et al., 2002) . For antisense Snail, primers were: 5 0 cgtagagctgacctcgctgtccgat3 0 and 5 0 ggatcctaatacgactcactatagg gagacttgtggagcaaggacatgcgg3 0 . For the Snail sense control probe, primers were: 5 0 ggatcctaatacgactcactatagggagagccg gaagcccaactatagcga3 0 and 5 0 ttcagagcgcccaggctgaggtact3 0 . Hybridized transcripts were detected using enzyme-antibody conjugates and the alkaline phosphatase substrate BCIP/ NBT Blue (Sigma, #B3804). Counterstaining was performed using Nuclear Fast Red (Sigma, #N3020).
Immunoblot analysis
Cells were lysed in Laemlli buffer and extracts were quantitated as described (Sheffield et al., 1987) . An immunoaffinity purified, rabbit antibody raised against residues 410-427 of human Gli1 was used at 1.7 mg/ml (Geneka/Active Motif). E-cadherin antibody (BD Biosciences, #610181) was used at 0.1 mg/ml, and b-Actin antibody (Sigma, #A5316) was used at 0.26 mg/ml. Bound antibodies were detected using the ECL method (Amersham Biosciences).
In vivo BrdU incorporation BrdU reagent (Zymed, #40286619, 1.0 ml/100 g body weight) was injected into the peritoneum 2 h before killing. BrdU was detected by immunostaining of paraffin sections as directed by Zymed (#93-3943).
